INS and atherosclerosis: Such a defect in insulin signaling not only impairs the utilization of glucose and lipids, but also causes accelerated atherosclerosis and the development of organ complications such as hypertension, atherogenic dyslipidemia, metabolic associated fatty liver disease, and many others [2].